The Invus Group Revenue and Competitors
Estimated Revenue & Valuation
- The Invus Group's estimated annual revenue is currently $15M per year.
- The Invus Group's estimated revenue per employee is $185,185
Employee Data
- The Invus Group has 81 Employees.
- The Invus Group grew their employee count by 5% last year.
The Invus Group Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $3.5M | 18 | 0% | N/A | N/A |
#2 | N/A | 19 | -21% | N/A | N/A |
#3 | $7.5M | 57 | 21% | N/A | N/A |
#4 | $11830M | 36 | 44% | $1M | N/A |
#5 | $7.5M | 48 | 50% | $48.1M | N/A |
#6 | $15M | 123 | 17% | N/A | N/A |
#7 | N/A | 8 | -88% | N/A | N/A |
#8 | N/A | 24 | -11% | N/A | N/A |
#9 | N/A | 16 | 14% | N/A | N/A |
#10 | $7.5M | 53 | 20% | N/A | N/A |
What Is The Invus Group?
Evergreen structure with over $5 billion under management. Offices in New York, Paris, and Hong Kong.
keywords:N/A
N/A
Total Funding
81
Number of Employees
$15M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
The Invus Group's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Managing Dir Private Equity/Boston | Reveal Email/Phone |
2 | Managing Director | Reveal Email/Phone |
3 | Managing Director | Reveal Email/Phone |
4 | Office Manager | Reveal Email/Phone |
5 | VP Finance | Reveal Email/Phone |
6 | Director | Reveal Email/Phone |
7 | Executive Assistant To CEO | Reveal Email/Phone |
8 | Head Macro & Quantitative Research | Research Analyst | Reveal Email/Phone |
9 | Director | Reveal Email/Phone |
10 | Chief Financial Officer | Reveal Email/Phone |
The Invus Group News
... Fidelity Management & Research Company, MPM Capital, F2 Ventures, Redmile Group, EcoR1 Capital, Samsara BioCapital, The Invus Group,...
- Recurring revenues corresponding to royalties on sales received by the Group pursuant to the agreement with Biogen. In 2020, these revenues...
... and CEO of The Invus Group, LLC, a New York-based global investment firm. ... practices of its board of directors and executive team,...
... by founding investor Syncona and joined by important new investors including Forbion, Invus, Perceptive Advisors and Redmile Group.
Achilles Therapeutics, a UK biotech focusing on personalised immunotherapy for cancer, has closed a £100m Series B funding round that ...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $11.3M | 81 | -15% | $11.5M |
#2 | $11.7M | 81 | -12% | $72.4M |
#3 | $18.5M | 81 | 11% | N/A |
#4 | $10.5M | 81 | 21% | $10.1M |
#5 | $18.4M | 81 | -13% | $16M |
The Invus Group Executives
| Name | Title |
|---|---|
| Raymond Debbane | CEO/President |
| Angela Florea | Executive Assistant To Chief Executive Officer |
| Philip Bafundo | Chief Financial Officer |
| Arshaad Yar | Chief Information Officer |
| Raymond Debbane | CEO/President |
| Chris Jiang | Vice President, Private Equity, Asian Emerging Markets |
| Addy Ho | VP, Public Equity, Hong Kong |
| Jack Ng | VP of Finance |
| Georgios Theophanous | Vice President |
| Lena Beaini | Associate VP - Operations |